---
title: 'Director, Clinical Operations at Vesalius Therapeutics'
canonical: 'https://feeny.ai/job/director-clinical-operations-vesalius-therapeutics-cambridge-yrx9wg8d798e'
type: 'job'
last_seen: '2026-09-13'
---

# Director, Clinical Operations at Vesalius Therapeutics

- **Company:** Vesalius Therapeutics
- **Location:** Cambridge, MA
- **Posted:** 2026-09-02
- **Last confirmed live:** 2026-09-13
- **Apply:** https://job-boards.greenhouse.io/vesalius/jobs/8758650002

## Job description

What if you could join a rapidly growing company and play a critical role in bringing new medicines to patients by helping scale the programmable infrastructure behind a new human cellular biology platform?

## About Vesalius

Vesalius Therapeutics is advancing a novel therapeutic program in Alzheimer’s disease. We are building an early clinical development capability designed to generate rigorous, decision-enabling human data and rapidly translate scientific insight into clinical proof of biological relevance.  This program represents the first of our clinical pipeline, with additional therapeutic programs expected to advance toward the clinic over time.

## Role Overview

Vesalius Therapeutics is seeking an experienced, hands-on Director of Clinical Operations to lead the operational execution of an innovative early-stage clinical development program in Alzheimer’s disease. This individual will play a critical role in translating clinical strategy into high-quality, efficiently executed studies and will partner closely with cross-functional leaders across Clinical Development, Clinical Pharmacology, Biostatistics, Data Management, Regulatory, and CMC.

The program is designed to progress from early clinical characterization in older adults to proof of biological relevance in an enriched Alzheimer’s disease population. Studies will integrate clinical pharmacology, objective physiologic and functional assessments, exploratory biomarkers, and quantitative measures of treatment response to support rapid, data-driven development decisions.

The ideal candidate thrives in a lean, high-ownership biotechnology environment, combines strong sponsor accountability with detailed execution, and can integrate multiple specialist vendors and scientific workstreams into a disciplined clinical program.

## Key Responsibilities

Clinical Program Ownership

- Own operational delivery of the clinical program from final protocol development through study start-up, enrollment, execution, database lock, and close-out.
- Lead execution of early clinical studies in older adults and subsequent studies in an early Alzheimer’s disease population, including complex randomized and crossover designs.
- Translate scientific objectives into operationally executable studies incorporating clinical pharmacology, pharmacokinetic, biomarker, physiologic, functional, cognitive, and safety assessments.
- Partner closely with Clinical Development, Clinical Pharmacology, Biostatistics, Data Management, Regulatory, and CMC to support integrated program execution and development decisions.

Clinical Trial Execution

- Partner with Clinical Development and Clinical Pharmacology to operationalize fit-for-purpose PK and PK/PD strategies, ensuring that sampling, processing, and study procedures preserve the integrity of key pharmacokinetic and pharmacodynamic assessments.
- Ensure study procedures preserve the integrity and quality of decision-critical objective assessments and data.
- Own clinical supply operations, randomization and blinding implementation, investigational product accountability, study-specific pharmacy procedures, and operational implementation of clinic- and home-based dosing.
- Develop recruitment and retention strategies appropriate for older adults and participants with early Alzheimer’s disease.
- Lead development and implementation of study plans, vendor specifications, manuals, monitoring approaches, training materials, and fit-for-purpose operational procedures.
- Ensure studies are conducted in accordance with the protocol, GCP, applicable regulatory requirements, and Vesalius quality standards, maintaining inspection-ready study documentation throughout execution.
- Ensure timely, complete, and inspection-ready Trial Master File documentation and appropriate oversight of CRO-maintained study records.
- Support IND/CTA preparation and regulatory authority interactions as appropriate.

CRO, Site & Vendor Management

- Establish and manage CROs, clinical research units, central and bioanalytical laboratories, biomarker vendors, technology partners, and other specialty service providers, with clear accountability for quality, timelines, and performance.
- Lead vendor selection and operational contracting in partnership with Finance and Legal, and maintain accountability for study budgets, forecasts, change orders, timelines, and vendor performance.
- Maintain clear visibility of critical path, enrollment, cost, data quality, vendor performance, and operational risks, and communicate status and recommendations clearly to senior leadership.

Organizational Contribution

- Build scalable clinical operations processes and infrastructure capable of supporting rapid progression from early clinical development into subsequent proof-of-concept studies.
- Provide leadership, mentorship, and oversight to internal and external Clinical Operations resources as the program and organization grow.

## Qualifications

- Experience in Alzheimer’s disease, mild cognitive impairment (MCI), neurodegenerative disease, or adjacent CNS/neurology indications.
- Early-stage CNS clinical development experience.
- Experience with clinical pharmacology and PK/PD studies.
- Experience with biomarker-intensive clinical trials and objective or technology-enabled clinical assessments.
- Familiarity with population PK, exposure-response, or model-informed drug development.
- Experience conducting studies involving older adults or cognitively impaired participants.
- Experience supporting IND/CTA preparation and interactions with FDA, MHRA, or other major regulatory authorities.

Leadership Profile

- Demonstrates strong sponsor ownership and accountability rather than relying solely on CRO-led execution.
- Comfortable moving between strategic program questions and detailed study execution.
- Balances scientific rigor with pragmatic, fit-for-purpose operational execution.
- Anticipates execution risks before they affect enrollment, timelines, cost, or data quality.
- Works effectively across clinical, scientific, regulatory, biometrics, and CMC functions.
- Communicates clearly and concisely with senior leadership and cross-functional partners.
- Thrives in an environment where speed, scientific rigor, collaboration, and pragmatic decision-making are equally important.

What Success Looks Like

The successful candidate will build and lead the operational capability required to execute the program’s early clinical studies on time, on budget, and to a high standard. They will drive disciplined study start-up and execution, effective CRO/site/vendor performance, strong enrollment and retention, robust clinical supply and study logistics, proactive risk management, inspection-ready documentation, and delivery of complete, high-quality data to support timely program decisions and progression through key clinical milestones.

At Flagship, we accept impossible missions to enable bigger leaps. Our [core values](https://www.flagshippioneering.com/values) guide us through uncertainty and toward lasting impact.

We are an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, protected veteran status, or any other characteristic protected by law.

We recognize that great candidates often bring unique strengths without fulfilling every qualification. If you have some of the experience listed above but not all, please apply anyway. We are dedicated to building diverse and inclusive teams and look forward to learning more about your background and interest in Flagship.

Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

The salary range for this role is $183,000 - $231,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Vesalius Therapeutics currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Vesalius Therapeutics's good faith estimate as of the date of publication and may be modified in the future.

## About Vesalius Therapeutics

## Core Business
- **Primary industry**: Biotechnology / Drug Discovery & Development
- **Target customers**: B2B (partners like GSK) and ultimately patients with common diseases (heart failure, type II diabetes, Alzheimer’s, NASH, obesity, Parkinson’s)
- **Mission or purpose**: “To fundamentally reconceptualize the way we view, diagnose, and treat common diseases” – focusing on the 90% of human illness that current approaches have struggled to address.

## Products & Services
- **Physio-Logic Platform**: A proprietary AI-driven discovery engine that analyzes clinical and genetic data from large patient groups to identify novel disease subtypes and drug targets. It validates insights using patient-derived cell-based models, streamlining drug discovery and increasing clinical trial success rates. [vesaliustx.com](https://www.vesaliustx.com/)
- **Pipeline (Parkinson’s Disease)**: In November 2024, Vesalius entered a multi-target strategic alliance with GSK to discover and develop novel treatments for Parkinson’s disease. [vesaliustx.com](https://www.vesaliustx.com/press/vesalius-announces-multi-target-strategic-alliance-with-gsk-to-develop-breakthrough-treatments-for-people-afflicted-with-parkinsons-disease/)
- **Other Indications**: The platform is being applied to heart failure, type II diabetes, Alzheimer’s disease, NASH, obesity, and other common diseases. [vesaliustx.com](https://www.vesaliustx.com/)

## Market Standing
- **Valuation/Market Cap**: Not disclosed (private company)
- **Total Funding**: $155M raised to date (includes initial $75M commitment from Flagship Pioneering and subsequent rounds, with corporate minority investment from GSK and participation by ARCH Venture Partners). [cbinsights.com](https://www.cbinsights.com/company/vesalius-therapeutics)
- **Notable Investors/Partners**: Flagship Pioneering (founder and lead investor), GSK (strategic alliance and investor), ARCH Venture Partners. [cbinsights.com](https://www.cbinsights.com/company/vesalius-therapeutics)
- **Growth Signals**: 
  - Multi-target alliance with GSK for Parkinson’s (Nov 2024).
  - New CEO appointed in Sept 2025 (Yasir Al-Wakeel, CEO-Partner of Flagship).
  - Active hiring for senior roles (Head of Biology, AI Enablement, Computational Biology).
  - Platform described as “revolutionary” by Flagship.

## Competitive Advantages
- **AI‑driven patient stratification**: Uses AI and machine learning to uncover previously unrecognized clinical patterns and gene circuits, enabling precision targeting of diseases that were historically treated as monolithic.
- **Proprietary human‑based models**: Patient-derived cell-based experimental models that better recapitulate human disease biology than traditional animal models.
- **Flagship Pioneering ecosystem**: Access to deep capital, entrepreneurial expertise, and a network of other Flagship-founded companies.
- **Focus on common diseases with high unmet need**: Targets the 90% of human illness where drug development has stagnated, offering a massive addressable market.

## Strategic Focus
- **Deepening the pipeline**: Advancing the GSK Parkinson’s alliance while expanding into other common diseases (cardiometabolic, neurodegenerative).
- **Platform scaling**: Continuing to refine the Physio-Logic platform with larger datasets and more sophisticated AI/ML models.
- **Talent acquisition**: Building a world-class team across computational biology, AI, drug development, and research. [greenhouse.io](https://job-boards.greenhouse.io/vesalius)

## Why Work Here
- **Culture**: The company describes itself as “fearless, focused, agile, data-driven and persistent,” with a strong emphasis on teamwork and continuous learning. [vesaliustx.com](https://www.vesaliustx.com/careers/)
- **Work environment**: Based in Cambridge, MA (620 Memorial Drive) – a hub for biotech innovation. The office policy is not explicitly stated, but the majority of roles listed are on-site in Cambridge.
- **Perks & engineering culture**: Opportunity to work at the intersection of AI, genomics, and drug discovery within a well-funded Flagship company. Roles include cutting-edge computational biology, machine learning, and AI enablement. Employees get exposure to a high-caliber scientific advisory board and leadership team with deep industry experience.
- **Growth trajectory**: With a recent GSK partnership and active hiring, the company is in a growth phase, offering significant career development potential.

## Sources
1. [vesaliustx.com](https://www.vesaliustx.com/) – Company website (platform, mission, leadership, careers)
2. [flagshippioneering.com](https://www.flagshippioneering.com/companies/vesalius-therapeutics) – Flagship Pioneering company page (overview, founding, news)
3. [cbinsights.com](https://www.cbinsights.com/company/vesalius-therapeutics) – Funding, investors, headquarters, stage
4. [greenhouse.io](https://job-boards.greenhouse.io/vesalius) – Active job listings (roles, location)
5. [vesaliustx.com/press](https://www.vesaliustx.com/press/vesalius-announces-multi-target-strategic-alliance-with-gsk-to-develop-breakthrough-treatments-for-people-afflicted-with-parkinsons-disease/) – GSK alliance announcement

## Other roles at Vesalius Therapeutics

- [Senior Automation Engineer, Platform Biology](https://feeny.ai/job/senior-automation-engineer-platform-biology-vesalius-therapeutics-cambridge-c3y5p6dr249e) — Cambridge, MA
- [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-flagship-pioneering-inc-cambridge-yqwgt65334cb) — Cambridge, MA
- [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-maze-therapeutics-south-san-francisco-8bfjmd3vbqe7) — South San Francisco, CA
- [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-oruka-therapeutics-waltham-massachusetts-dmf2nbp3y8nt) — Waltham Massachusetts, United States